Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. / Trepiakas, Redas; Berntsen, Annika; Hadrup, Sine Reker; Bjørn, Jon; Geertsen, Poul F; Straten, Per Thor; Andersen, Mads H; Pedersen, Anders Elm; Soleimani, Amir; Lorentzen, Torben; Johansen, Julia S; Svane, Inge Marie.

I: Cytotherapy, Bind 12, Nr. 6, 01.10.2010, s. 721-34.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Trepiakas, R, Berntsen, A, Hadrup, SR, Bjørn, J, Geertsen, PF, Straten, PT, Andersen, MH, Pedersen, AE, Soleimani, A, Lorentzen, T, Johansen, JS & Svane, IM 2010, 'Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial', Cytotherapy, bind 12, nr. 6, s. 721-34. https://doi.org/10.3109/14653241003774045, https://doi.org/10.3109/14653241003774045

APA

Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, M. H., Pedersen, A. E., Soleimani, A., Lorentzen, T., Johansen, J. S., & Svane, I. M. (2010). Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. Cytotherapy, 12(6), 721-34. https://doi.org/10.3109/14653241003774045, https://doi.org/10.3109/14653241003774045

Vancouver

Trepiakas R, Berntsen A, Hadrup SR, Bjørn J, Geertsen PF, Straten PT o.a. Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. Cytotherapy. 2010 okt. 1;12(6):721-34. https://doi.org/10.3109/14653241003774045, https://doi.org/10.3109/14653241003774045

Author

Trepiakas, Redas ; Berntsen, Annika ; Hadrup, Sine Reker ; Bjørn, Jon ; Geertsen, Poul F ; Straten, Per Thor ; Andersen, Mads H ; Pedersen, Anders Elm ; Soleimani, Amir ; Lorentzen, Torben ; Johansen, Julia S ; Svane, Inge Marie. / Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. I: Cytotherapy. 2010 ; Bind 12, Nr. 6. s. 721-34.

Bibtex

@article{bdbf71fc0c63438d9e9e13ad4aaf28c3,
title = "Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial",
abstract = "Dendritic cells are regarded as the most effective antigen presenting cells and coordinators of the immune response and therefore suitable as vaccine basis. Here we present results from a clinical study in which patients with malignant melanoma (MM) with verified progressive disease received vaccination with autologous monocyte-derived mature dendritic cells (DC) pulsed with p53, survivin and telomerase-derived peptides (HLA-A2+ patients) or with autologous/allogeneic tumor lysate (HLA-A2(-) patients) in combination with low-dose interleukin (IL)-2 and interferon (IFN)-alpha2b.",
author = "Redas Trepiakas and Annika Berntsen and Hadrup, {Sine Reker} and Jon Bj{\o}rn and Geertsen, {Poul F} and Straten, {Per Thor} and Andersen, {Mads H} and Pedersen, {Anders Elm} and Amir Soleimani and Torben Lorentzen and Johansen, {Julia S} and Svane, {Inge Marie}",
year = "2010",
month = oct,
day = "1",
doi = "10.3109/14653241003774045",
language = "English",
volume = "12",
pages = "721--34",
journal = "Cytotherapy",
issn = "1465-3249",
publisher = "Elsevier",
number = "6",

}

RIS

TY - JOUR

T1 - Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

AU - Trepiakas, Redas

AU - Berntsen, Annika

AU - Hadrup, Sine Reker

AU - Bjørn, Jon

AU - Geertsen, Poul F

AU - Straten, Per Thor

AU - Andersen, Mads H

AU - Pedersen, Anders Elm

AU - Soleimani, Amir

AU - Lorentzen, Torben

AU - Johansen, Julia S

AU - Svane, Inge Marie

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Dendritic cells are regarded as the most effective antigen presenting cells and coordinators of the immune response and therefore suitable as vaccine basis. Here we present results from a clinical study in which patients with malignant melanoma (MM) with verified progressive disease received vaccination with autologous monocyte-derived mature dendritic cells (DC) pulsed with p53, survivin and telomerase-derived peptides (HLA-A2+ patients) or with autologous/allogeneic tumor lysate (HLA-A2(-) patients) in combination with low-dose interleukin (IL)-2 and interferon (IFN)-alpha2b.

AB - Dendritic cells are regarded as the most effective antigen presenting cells and coordinators of the immune response and therefore suitable as vaccine basis. Here we present results from a clinical study in which patients with malignant melanoma (MM) with verified progressive disease received vaccination with autologous monocyte-derived mature dendritic cells (DC) pulsed with p53, survivin and telomerase-derived peptides (HLA-A2+ patients) or with autologous/allogeneic tumor lysate (HLA-A2(-) patients) in combination with low-dose interleukin (IL)-2 and interferon (IFN)-alpha2b.

U2 - 10.3109/14653241003774045

DO - 10.3109/14653241003774045

M3 - Journal article

C2 - 20429791

VL - 12

SP - 721

EP - 734

JO - Cytotherapy

JF - Cytotherapy

SN - 1465-3249

IS - 6

ER -

ID: 32304621